Skip to main content

Table 2 SNPs taken a genome-wide association study on PD used for stratification of patients (omics+/− groups)

From: An omics-based strategy using coenzyme Q10 in patients with Parkinson’s disease: concept evaluation in a double-blind randomized placebo-controlled parallel group trial

SNP

Locus

Effect allele

MAF

Odds Ratio

rs329648

MIR4697

T

0,46

1,15

rs34311866

TMEM175-GAK-DGKQ

G

0,14

1,40

rs11868035

SREBF1-RAI1

A

0,49

0,97

rs14235

BCKDK-STX1B

A

0,36

1,19

rs11060180

CCDC62

G

0,25

0,90

rs71628662

GBA-SYT11

T

0,01

0,40

rs199347

GPNMB

C

0,48

0,97

rs12637471

MCCC1

A

0,34

0,67

  1. SNPs were taken from the study of Nalls et al. [6]. Only SNPs were taken into account with an in silico annotation to mitochondrial homeostasis. SNP: single nucleotide polymorphism. MAF: mean allele frequency
Back to article page

Neurological Research and Practice

ISSN: 2524-3489

Contact us